Insider trading

Period: 12 months Type of trade: Sold × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

46,041 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

46,041 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

46,041 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

46,041 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
46,041 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
46,041 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

46,041 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
10 Mar 2026
Farquhar John C.M. Chief Executive Officer
Sold on a plan
$290.89K 12,837 at 22.66
2.2%
Planned (10b5-1)
10 Mar 2026
Sold at will
$290.25K 75,000 at 3.87
9.2%
Not planned
10 Mar 2026
Santana Rafael President and CEO
Sold on a plan 6×
$289.39K 1,163 at 248.83
0.6%
Planned (10b5-1)
10 Mar 2026
RUBINSTEIN JULIE President and COO
Sold on a plan
$285.67K 19,460 at 14.68
2.9%
Planned (10b5-1)
10 Mar 2026
Hanstveit Arve Director
Sold at will
$273.98K 25,000 at 10.96
4.3%
Not planned
10 Mar 2026
Semah Victor Chief Legal Officer
Sold on a plan
$269.69K 5,498 at 49.05
18.1%
Planned (10b5-1)
10 Mar 2026
Kirscht Patrick Chief Credit Officer
Sold at will 4×
$266.07K 54,299 at 4.90
11.0%
Not planned
10 Mar 2026
Susi Roger E. CEO, PRESIDENT, CHAIRMAN · indirect
Sold at will
$250.28K 2,500 at 100.11
0.1%
Not planned
10 Mar 2026
Horich William Todd SVP, Commercial Operations
Sold at will
$244.15K 4,439 at 55.00
100%
Sold half or more
10 Mar 2026
TOTH A ERNEST JR Chief Financial Officer
Sold at will
$243.09K 58,254 at 4.17
13.4%
Not planned
10 Mar 2026
Buch Anand Chief Strategy Officer
Sold at will 2×
$238.03K 34,315 at 6.94
6.0%
Not planned
10 Mar 2026
Lin Mark EVP and CFO
Sold on a plan
$233.13K 2,734 at 85.27
8.2%
Planned (10b5-1)
10 Mar 2026
Raiford Daryl E Chief Financial Officer
Sold at will
$228.40K 14,000 at 16.31
15.1%
Not planned
10 Mar 2026
Glennan Sean Joseph Chief Financial Officer
Sold on a plan
$226.87K 4,625 at 49.05
27.7%
Planned (10b5-1)
10 Mar 2026
KUEHN KURT P Director
Sold at will
$224.57K 2,844 at 78.96
15.6%
Not planned
10 Mar 2026
Desale Pravin SVP, R&D
Sold at will
$218.64K 2,366 at 92.41
2.8%
Not planned
10 Mar 2026
Datar Srikant M. Director · indirect
Sold at will
$218.25K 1,000 at 218.25
8.4%
Not planned
10 Mar 2026
Lucas Shannon President & COO · indirect
Sold on a plan
$208.26K 11,700 at 17.80
0.7%
Planned (10b5-1)
10 Mar 2026
Sankarlingam Velchamy Pres. of Engineering & Product
Sold on a plan
$202.64K 2,590 at 78.24
1.9%
Planned (10b5-1)
10 Mar 2026
Jung Cassie Chief Operating Officer
Sold at will
$191.09K 45,791 at 4.17
14.3%
Not planned
10 Mar 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$186.78K 915 at 204.13
0.6%
Planned (10b5-1)
10 Mar 2026
Ozuna Christina M. Chief Claims Officer
Sold at will
$179.46K 4,500 at 39.88
23.1%
Not planned
10 Mar 2026
Allison Jonathan Chief Administrative Officer
Sold on a plan
$175.38K 3,900 at 44.97
4.0%
Planned (10b5-1)
10 Mar 2026
TZIANABOS ARTHUR Interim Executive Chair
Sold on a plan
$174.21K 4,355 at 40.00
12.2%
Planned (10b5-1)
10 Mar 2026
Trimberger Lisa G Director · indirect
Sold at will
$172.15K 3,000 at 57.38
100%
Sold half or more
10 Mar 2026
BRAENDER LORI J Chief Legal Officer
Sold at will
$167.35K 40,102 at 4.17
8.3%
Not planned
10 Mar 2026
KENNEY CHRISTOPHER JOHN Chief Medical Officer
Sold on a plan
$166.56K 2,771 at 60.11
36.9%
Planned (10b5-1)
10 Mar 2026
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$160.24K 785 at 204.13
1.2%
Planned (10b5-1)
10 Mar 2026
Sold on a plan
$157.85K 333 at 474.01
2.3%
Planned (10b5-1)
10 Mar 2026
DiFabio Andrea Chief Legal Officer
Sold on a plan
$156.70K 2,607 at 60.11
34.8%
Planned (10b5-1)
10 Mar 2026
Sold at will
$156.58K 944 at 165.87
1.9%
Not planned
10 Mar 2026
Dowden Nathan J President & COO
Sold on a plan
$155.19K 11,894 at 13.05
5.7%
Planned (10b5-1)
10 Mar 2026
WENTWORTH KORY JAMES Chief Financial Officer
Sold on a plan
$148.22K 11,388 at 13.02
8.6%
Planned (10b5-1)
10 Mar 2026
Shaikh Erhaan SVP, Sales
Sold at will
$147.17K 1,577 at 93.33
1.9%
Not planned
10 Mar 2026
Schwartz Larissa See Remarks
Sold on a plan
$146.68K 1,836 at 79.89
2.3%
Planned (10b5-1)
10 Mar 2026
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$144.32K 707 at 204.13
0.4%
Planned (10b5-1)
10 Mar 2026
Calmes John L Jr See remarks
Sold at will
$141.88K 1,000 at 141.88
1.9%
Not planned
10 Mar 2026
MIHAYLO STEVEN G Director · indirect
Sold at will 3×
$140.61K 19,994 at 7.03
0.2%
Not planned
10 Mar 2026
ZOI MIKE 10% owner · indirect
Sold at will
$140.40K 31,131 at 4.51
2.6%
Not planned
10 Mar 2026
FAHEY JOHN M JR Director
Sold at will
$137.19K 7,768 at 17.66
5.9%
Not planned
10 Mar 2026
Bergwall Timothy SVP, Chief Commercial Officer
Sold on a plan
$134.98K 2,000 at 67.49
2.7%
Planned (10b5-1)
10 Mar 2026
Demmerle Stefan Vice President
Sold at will
$132.58K 2,500 at 53.03
1.1%
Not planned
10 Mar 2026
Gryzlov Yury CHIEF OPERATING OFFICER
Sold on a plan
$132.27K 21,266 at 6.22
3.9%
Planned (10b5-1)
10 Mar 2026
Bayview Legacy, LLC 10% owner · indirect
Sold on a plan
$131.97K 9,000 at 14.66
0.1%
Planned (10b5-1)
10 Mar 2026
JANAC K CHARLES President and CEO · indirect
Sold on a plan
$131.97K 9,000 at 14.66
0.1%
Planned (10b5-1)
10 Mar 2026
Kashani Ali Chief Executive Officer
Sold at will
$131.22K 13,500 at 9.72
0.4%
Not planned
10 Mar 2026
Remer Eric Richard Chief Executive Officer
Sold on a plan
$131.08K 11,047 at 11.87
0.4%
Planned (10b5-1)
10 Mar 2026
Sold at will
$131.01K 10,695 at 12.25
10.6%
Not planned
10 Mar 2026
Boyd Peter E. Chief People Officer
Sold at will
$124.41K 29,814 at 4.17
8.1%
Not planned
10 Mar 2026
Sold at will 3×
$123.84K 6,000 at 20.64
3.8%
Not planned
Showing 27,901–27,950 of 46,041. ← Newer Page 559 of 921 Older →